Acute Agitation Completed Phase 1 Trials for Olanzapine (DB00334)

Also known as: Agitation / Excitement abnormal / Feeling agitated / Agitated

IndicationStatusPhase
DBCOND0078942 (Acute Agitation)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03624322Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101Treatment